Taken together, the data show that although PDE4 is a substantial contributor to cAMP hydrolysis in PASMCs, limiting vasorelaxation and promoting cell proliferation, it is not significantly altered in PAH. Here, PDE4A is linked to pulmonary arterial hypertension.